Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Anything coming out of the pipeline?
Jan 29, 2003

Dr. Young: Hi. Any new meds to hit the streets soon? Thanks for your service on thebody.com Stan

Response from Dr. Young

Stan- thanks for your question.

Yes, there are products in the pipeline that should soon "hit the streets". In 2003, we should see at least three new HIV medications approved by the US FDA.

The fusion inhibitor, enfuvirtide (Fuzeon, T-20) and new protease inhibitors, atazanavir and fos-amprenavir (GW908) either have or will submit papers seeking approval by the FDA this year. Street talk has it that all three drugs should be available within months.

I'd advise you to keep checking the postings or meeting reviews on TheBody or the individual pharmaceutical's websites (Roche, BMS and GSK, respectively)for an up to date information about the new products. -BY



Previous
how risky is oral sex hiv transmission?
Next
Advice on CD4 Count

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement